Advances and novel developments in environmental influences on the development of atopic diseases
- PMID: 33037680
- PMCID: PMC12087019
- DOI: 10.1111/all.14624
Advances and novel developments in environmental influences on the development of atopic diseases
Abstract
Although genetic factors play a role in the etiology of atopic disease, the rapid increases in the prevalence of these diseases over the last few decades suggest that environmental, rather than genetic factors are the driving force behind the increasing prevalence. In modern societies, there is increased time spent indoors, use of antibiotics, and consumption of processed foods and decreased contact with farm animals and pets, which limit exposure to environmental allergens, infectious parasitic worms, and microbes. The lack of exposure to these factors is thought to prevent proper education and training of the immune system. Increased industrialization and urbanization have brought about increases in organic and inorganic pollutants. In addition, Caesarian birth, birth order, increased use of soaps and detergents, tobacco smoke exposure and psychosomatic factors are other factors that have been associated with increased rate of allergic diseases. Here, we review current knowledge on the environmental factors that have been shown to affect the development of allergic diseases and the recent developments in the field.
Keywords: allergy; atopic disease; environment; exposome; pollution.
© 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
Conflict of interest statement
Conflict of Interest:
Shifaa Alkotob, Vanitha Sampath, Cade Cannedy, Katharina Harter, Hesam Movassagh, Qi Zhao, Bibek Paudel, Mary Prunicki, Eric Smith, and Tamara Schikowski declare no conflict of interest. Claudia Traidl-Hoffmann reports grants for research and development of CK-CARE, Sebapharma, Töpfer, Traidl-Hoffmann is involved in Clinical trials with Assana; Data and Safety Monitoring Board member at Novartis Personal fees from Novartis, Töpfer, Sebapharma; Consultant and Advisory Board Member at Novartis, Sanofi, Lilly Pharma; Dr. Nadeau reports grants from National Institute of Allergy and Infectious Diseases (NIAID), National Heart, Lung, and Blood Institute (NHLBI), and National Institute of Environmental Health Sciences (NIEHS); Food Allergy Research & Education (FARE), Director of World Allergy Organization (WAO) Center of Excellence at Stanford; Advisor at Cour Pharma; Co-founder of Before Brands, Alladapt, Latitude, and IgGenix; National Scientific Committee member at Immune Tolerance Network (ITN) and National Institutes of Health (NIH) clinical research centers; DSMB member for NHLBI, US patents for basophil testing, multifood immunotherapy and prevention, monoclonal antibody from plasmoblasts, and device for diagnostics.
Figures
References
-
- Doll RJ, Joseph NI, McGarry D, Jhaveri D, Sher T, R. H. Epidemiology of Allergic Diseases. . In: M M, editor. Allergy and Asthma. Cham: Springer; 2019.
-
- Gilles S, Akdis C, Lauener R, et al. The role of environmental factors in allergy: A critical reappraisal. Exp Dermatol 2018;27:1193–1200. - PubMed
-
- Feuerecker M, Crucian BE, Quintens R, et al. Immune sensitization during 1 year in the Antarctic high-altitude Concordia Environment. Allergy 2019;74:64–77. - PubMed
-
- Haahtela T A biodiversity hypothesis. Allergy 2019;74:1445–1456. - PubMed
-
- Fairweather V, Hertig E, Traidl-Hoffmann C. A brief introduction to climate change and health. Allergy 2020;75:2352–2354. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
